Filing Details

Accession Number:
0001703057-23-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-09 12:22:00
Reporting Period:
2023-08-08
Accepted Time:
2023-08-09 12:22:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1703057 Abcellera Biologics Inc. ABCL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352908 R Michael Hayden C/O Abcellera Biologics Inc
2215 Yukon Street
Vancouver A1
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2023-08-08 30,000 $5.90 1,303,397 No 5 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 118,245 Indirect By spouse
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $5.89 to $5.91. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  2. These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.